Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages

International Journal of Pharmaceutics

Volumn 430, Issue 1-2, 2012, Pages 207-215

  Almouazen, Eyad ^a   Bourgeois, Sandrine ^a   Boussaïd, Ali ^a   Valot, Pascale ^a   Malleval, Celine ^a   Fessi, Hatem ^a   Nataf, Serge ^a   Briançon, Stephanie ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Biodegradable polymeric nanoparticles; Drug delivery; Immunomodulation; Macrophages; Retinoic acid

Indexed keywords

CYTOKINE; NANOCAPSULE; NANOPARTICLE; POLYCAPROLACTONE; POLYLACTIC ACID; RETINOIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GLIOMA; MACROPHAGE; MONONUCLEAR PHAGOCYTE; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; CYTOKINES; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; GLIOMA; HUMANS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRALESIONAL; KINETICS; LACTIC ACID; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NANOCAPSULES; NANOTECHNOLOGY; OXAZINES; PHAGOCYTOSIS; POLYESTERS; POLYMERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TRETINOIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860727651     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.025     Document Type: Article

References (49)

1. C.C. Achkar, J.M. Bentel, J.F. Boylan, H.I. Scher, L.J. Gudas, and W.H. Miller Jr. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice Drug Metab. Dispos. 22 1994 451 458 (Pubitemid 24158547)
2. A.M. Al-Ghananeem, A.H. Malkawi, Y.M. Muammer, J.M. Balko, E.P. Black, W. Mourad, and E. Romond Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations AAPS Pharm. Sci. Technol. 10 2009 410 417
3. D. Alizadeh, L. Zhang, J. Hwang, T. Schluep, and B. Badie Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas Nanomedicine 6 2010 382 390
4. B. Badie, and J.M. Schartner Flow cytometric characterization of tumor-associated macrophages in experimental gliomas Neurosurgery 46 2000 957 961 discussion 961-962
5. M.K. Basu, and S. Lala Macrophage specific drug delivery in experimental leishmaniasis Curr. Mol. Med. 4 2004 681 689 (Pubitemid 39172370)
6. A. Bernardi, R.L. Frozza, E. Jager, F. Figueiro, L. Bavaresco, C. Salbego, A.R. Pohlmann, S.S. Guterres, and A.M. Battastini Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study Eur. J. Pharmacol. 586 2008 24 34
7. F. Chellat, Y. Merhi, A. Moreau, and L. Yahia Therapeutic potential of nanoparticulate systems for macrophage targeting Biomaterials 26 2005 7260 7275 (Pubitemid 41133578)
8. Y. Cirpanli, N. Unlu, S. Calis, and A.A. Hincal Formulation and in vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres J. Microencapsulation 22 2005 877 889 (Pubitemid 43158189)
9. C. Coester, P. Nayyar, and J. Samuel In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation Eur. J. Pharm. Biopharm. 62 2006 306 314 (Pubitemid 43356580)
10. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867 (Pubitemid 36019639)
11. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier Nanocapsule technology: a review Crit. Rev. Ther. Drug Carrier Syst. 19 2002 99 134
12. S. Darmanin, J. Chen, S. Zhao, H. Cui, R. Shirkoohi, N. Kubo, Y. Kuge, N. Tamaki, K. Nakagawa, J. Hamada, T. Moriuchi, and M. Kobayashi All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors J. Immunol. 179 2007 4616 4625
13. N. Davoust, C. Vuaillat, G. Cavillon, C. Domenget, E. Hatterer, A. Bernard, C. Dumontel, P. Jurdic, C. Malcus, C. Confavreux, M.F. Belin, and S. Nataf Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia FASEB J. 20 2006 2081 2092 (Pubitemid 44953907)
14. G.L. Defer, H. Adle-Biassette, F. Ricolfi, L. Martin, F.J. Authier, C. Chomienne, L. Degos, and J.D. Degos All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications J. Neurooncol. 34 1997 169 177 (Pubitemid 27271723)
15. H. Dou, J. Morehead, C.J. Destache, J.D. Kingsley, L. Shlyakhtenko, Y. Zhou, M. Chaubal, J. Werling, J. Kipp, B.E. Rabinow, and H.E. Gendelman Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages Virology 358 2007 148 158 (Pubitemid 46048870)
16. O.C. Farokhzad, J. Cheng, B.A. Teply, I. Sherifi, S. Jon, P.W. Kantoff, J.P. Richie, and R. Langer Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc. Natl. Acad. Sci. U.S.A. 103 2006 6315 6320
17. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int. J. Pharm. 55 1989 R1 R4
18. A. Gessner, A. Lieske, B. Paulke, and R. Muller Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis Eur. J. Pharm. Biopharm. 54 2002 165 170 (Pubitemid 34919390)
19. A. Gessner, R. Waicz, A. Lieske, B. Paulke, K. Mader, and R.H. Muller Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption Int. J. Pharm. 196 2000 245 249 (Pubitemid 30105753)
20. E.P. Goldberg, A.R. Hadba, B.A. Almond, and J.S. Marotta Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery J. Pharm. Pharmacol. 54 2002 159 180 (Pubitemid 34150053)
21. A.R. Hallahan, J.I. Pritchard, R.A. Chandraratna, R.G. Ellenbogen, J.R. Geyer, R.P. Overland, A.D. Strand, S.J. Tapscott, and J.M. Olson BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect Nat. Med. 9 2003 1033 1038 (Pubitemid 37021783)
22. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
23. B.L. Hogan Bone morphogenetic proteins: multifunctional regulators of vertebrate development Genes Dev. 10 1996 1580 1594 (Pubitemid 26268864)
24. S.J. Holland, B.J. Tighe, and P.L. Gould Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems J. Control. Release 4 1986 155 180 (Pubitemid 17204842)
25. Y.I. Jeong, M.K. Kang, H.S. Sun, S.S. Kang, H.W. Kim, K.S. Moon, K.J. Lee, S.H. Kim, and S. Jung All-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymer Int. J. Pharm. 273 2004 95 107 (Pubitemid 38317044)
26. V. Kanchan, and A.K. Panda Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response Biomaterials 28 2007 5344 5357 (Pubitemid 47532191)
27. S.G. Kang, H.W. Lim, O.M. Andrisani, H.E. Broxmeyer, and C.H. Kim Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells J. Immunol. 179 2007 3724 3733
28. A. Lamprecht, and J.P. Benoit Simple liquid-chromatographic method for NileRed quantification in cell culture in spite of photobleaching J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 787 2003 415 419 (Pubitemid 36316020)
29. M. Leroueil-Le Verger, L. Fluckiger, Y.I. Kim, M. Hoffman, and P. Maincent Preparation and characterization of nanoparticles containing an antihypertensive agent Eur. J. Pharm. Biopharm. 46 1998 137 143 (Pubitemid 28414471)
30. X. Li, R. Li, X. Qian, Y. Ding, Y. Tu, R. Guo, Y. Hu, X. Jiang, W. Guo, and B. Liu Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate Eur. J. Pharm. Biopharm. 70 2008 726 734
31. C. Liss, M.J. Fekete, R. Hasina, and M.W. Lingen Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma Int. J. Cancer 100 2002 283 289 (Pubitemid 34728985)
32. M.P. Melancon, W. Lu, Q. Huang, P. Thapa, D. Zhou, C. Ng, and C. Li Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813 Biomaterials 31 2010 6567 6573
33. R. Merino, and J.M. Hurle The molecular basis of retinoid action in tumors Trends Mol. Med. 9 2003 509 511 (Pubitemid 38017186)
34. C.E. Mora-Huertas, H. Fessi, and A. Elaissari Polymer-based nanocapsules for drug delivery Int. J. Pharm. 385 2010 113 142
35. D. Nickles, A. Abschuetz, H. Zimmer, T. Kees, R. Geibig, E. Spiess, and A. Regnier-Vigouroux End-stage dying glioma cells are engulfed by mouse microglia with a strain-dependent efficacy J. Neuroimmunol. 197 2008 10 20
36. A.F. Ourique, A.R. Pohlmann, S.S. Guterres, and R.C. Beck Tretinoin-loaded nanocapsules: preparation, physicochemical characterization, and photostability study Int. J. Pharm. 352 2008 1 4
37. D.E. Owens 3rd, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102 (Pubitemid 41773257)
38. K. Pino-Lagos, M.J. Benson, and R.J. Noelle Retinoic acid in the immune system Ann. N.Y. Acad. Sci. 1143 2008 170 187
39. S.K. Sahoo, and V. Labhasetwar Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention Mol. Pharm. 2 2005 373 383 (Pubitemid 41503678)
40. S.K. Sahoo, W. Ma, and V. Labhasetwar Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer Int. J. Cancer 112 2004 335 340 (Pubitemid 39244375)
41. C.E. Soma, C. Dubernet, G. Barratt, F. Nemati, M. Appel, S. Benita, and P. Couvreur Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages Pharm. Res. 16 1999 1710 1716 (Pubitemid 29530403)
42. S.Y. Sun, and R. Lotan Retinoids and their receptors in cancer development and chemoprevention Crit. Rev. Oncol. Hematol. 41 2002 41 55 (Pubitemid 34051581)
43. E.Z. Szuts, and F.I. Harosi Solubility of retinoids in water Arch. Biochem. Biophys. 287 1991 297 304
44. L. Taillandier, L. Antunes, and K.S. Angioi-Duprez Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice J. Neurosci. Methods 125 2003 147 157 (Pubitemid 36579343)
45. T. Trimaille, C. Pichot, A. Elaissari, H. Fessi, S. Briancon, and T. Delair Poly(d,l-lactic acid) nanoparticle preparation and colloidal characterization Colloid. Polym. Sci. 281 2003 1184 1190 (Pubitemid 37441626)
46. W. Ulbrich, and A. Lamprecht Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases J. R. Soc. Interface 7 Suppl. 1 2010 S55 S66
47. J.J. Watters, J.M. Schartner, and B. Badie Microglia function in brain tumors J. Neurosci. Res. 81 2005 447 455 (Pubitemid 41359299)
48. J. Xia, S. Zhang, Y. Zhang, M. Ma, K. Xu, M. Tang, and N. Gu The relationship between internalization of magnetic nanoparticles and changes of cellular optical scatter signal J. Nanosci. Nanotechnol. 8 2008 6310 6315
49. D. Zheng, D. Li, X. Lu, and Z. Feng Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery Oncol. Rep. 23 2010 717 724